Theravance Biopharma (TBPH) falls 21% as trading resumes after a trial missed the primary endpoint

August 23, 2021 4:37 PM

Theravance Biopharma (NASDAQ: TBPH) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found